Oct142022

Efficacy of the Adjuvanted Recombinant Zoster Vaccine (RZV) by Sex, Geographic Region, and Geographic Ancestry/Ethnicity: A Post-Hoc Analysis of the ZOE-50 and ZOE-70 Randomised Trials

Recent Publications

Herpes zoster (HZ) risk appears to vary by sex and geographic ancestry/ethnicity. In 2 randomised clinical trials, participants received 2 doses of adjuvanted recombinant zoster vaccine (RZV) or placebo intramuscularly, 2 months apart. In this post-hoc analysis, the efficacy of RZV against HZ and postherpetic neuralgia (PHN) were investigated by sex, geographic region, and geographic…

Read article
Oct142022

Locally Delivered Flurbiprofen 8.75 mg for Treatment and Prevention of Sore Throat: A Narrative Review of Clinical Studies

Recent Publications

Antibiotics are inappropriately prescribed to many people with sore throat. As most cases of sore throat are viral and/or self-limiting, guidelines recommend symptomatic management as first-line treatment. This paper reviews the available clinical evidence for the efficacy and safety of low dose (8.75 mg) flurbiprofen, locally delivered to the throat for the symptomatic management of…

Read article